HCV NS3-NS4A protease resistance mutants
US7494660B2 · kind B2 · utility
10Cited by
16References
23Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 27, 2004 |
| Grant date | Feb 24, 2009 |
| Priority date | — |
| Expiry date | Jun 11, 2025 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/18
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to mutants of HCV NS3/4A protease. More particularly, the present invention identifies mutant of HCV NS3/4A protease that are resistant to drug treatment.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.